Amgen (AMGN) Otezla Deal 'Highly Accretive' - Cowen
Tweet Send to a Friend
Cowen analyst Yaron Werber reiterated an Outperform rating and $231.00 price target on Amgen (NASDAQ: AMGN) after the company agreed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


